Global Stroke Revascularization Device Market 2022-2030

    Multi User License - $2,999

    In Stock

    Coming Soon

    GLOBAL STROKE REVASCULARIZATION DEVICE MARKET

     

    INTRODUCTION

     Revascularization device is a neurovascular self-expanding, retrievable device that resembles a stent and is used to reestablish blood flow in patients who have suffered an ischemic stroke due to a major intracranial artery obstruction.

     

    Infographics-Stroke Revascularization Device Market , Stroke Revascularization Device Market Size, Stroke Revascularization Device Market Trends, Stroke Revascularization Device Market Forecast, Stroke Revascularization Device Market Risks, Stroke Revascularization Device Market Report, Stroke Revascularization Device Market Share

     

    GLOBAL STROKE REVASCULARIZATION DEVICE MARKET SIZE AND FORECAST

     

    The global stroke revascularization  device market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.

     

    NEW PRODUCT LAUNCH

    The Solitaire X Revascularization Device has been made available, and Medtronic plc has announced its first patient trials for the treatment of acute ischemic stroke. Doctors have been able to help patients with stroke have a higher chance of recovering because of the industry-leading Solitaire Revascularization Device.

     

    The fourth generation of the Solitaire family of revascularization devices, Solitaire X, keeps the technical features that have made them very successful and clinically validated while incorporating an optimized distribution method for increased efficiency.

     

     Additionally, Medtronic unveils the Phenom 21 Catheter, a microcatheter with a length of 160 cm that can deliver all sizes of Solitaire X.Patients who have experienced an acute ischemic stroke with a major artery occlusion can regain blood flow by using the Solitaire X device, which mechanically eliminates blood clots from blocked brain vessels.

     

    Solitaire X offers a reduced clot crossing profile and seamless distribution to occlusions in distal arteries as small as 2.0 mm when used in conjunction with Phenom 21. With this suitable system, Medtronic is even more dedicated to the fight against stroke

     

    The Tigertriever Revascularization Device (RD), made by Rapid Medical Ltd., a subsidiary of MicroPort NeuroTech Co., Ltd.. Tigertriever is a totally retrievable medical gadget created to help patients with acute ischemic strokes regain blood flow. The mesh’s outer diameter is regulated by a handle, unlike any previous commercial device.

     

    Furthermore, Tigertriever is the only commercially available product that makes use of a unique 3D braided technique to build a mesh with a large pore size for optimal clot penetration. Tigertriever is made of an expandable wire shaft attached on a collapsible, totally retrievable, fine wire structure. A microcatheter is used to deliver the device intracranially.

     

    A suite of three devices called CERENOVUS Stroke Solutions, part of Johnson & Johnson Medical Devices Companies, has been introduced to help doctors perform clot removal treatments. With compatibility in mind, CERENOVUS Stroke Solutions were created to aid medical professionals in performing mechanical thrombectomy treatments.

     

    The range of technologies consists of: The newest generation stent retriever, the EMBOTRAP III Revascularization Device, is made to engage a variety of clot types, boost procedural confidence, and offer more specialised alternatives to accomplish the First Pass Effect (FPE)

     

    The latest component of Penumbra, Inc.’s extensive Penumbra System, the RED 62 Reperfusion Catheter, has received approval from the U.S. Food and Drug Administration and is now commercially available. Penumbra, Inc. is a worldwide healthcare company with a focus on cutting-edge therapeutics.

     

    Together with Penumbra ENGINE, RED 62 is made to manoeuvre through difficult distal artery anatomy and deliver forceful aspiration for the removal of blood clots in acute ischemic stroke patients with big vessel occlusions.

     

    It is designed to help revascularize patients who have experienced an acute ischemic stroke due to intracranial major vessel occlusions. Reperfusion Catheters, 3D Revascularization Device, Penumbra ENGINE aspiration source, and other accessories are included with the Penumbra System.

     

    COMPANY PROFILE

     

    THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. What is the average cost per global stroke revascularization  device market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a global stroke revascularization  device market in the US, Europe and China?
    3. How many global stroke revascularization  device markets are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a global stroke revascularization  device market and key vendor selection criteria
    6. Where is the global stroke revascularization  device market  manufactured? What is the average margin per equipment?
    7. Market share of global stroke revascularization  device market manufacturers and their upcoming products
    8. The most important planned global stroke revascularization  device market in next 2 years
    9. Details on network of major global stroke revascularization  device market and pricing plans
    10. Cost advantage for OEMs who manufacture global stroke revascularization  device market in-house
    11. 5 key predictions for next 5 years in global stroke revascularization  device market
    12. Average B-2-B global stroke revascularization  device market price in all segments
    13. Latest trends in global stroke revascularization  device market, by every market segment
    14. The market size (both volume and value) of global stroke revascularization  device market in 2022-2030 and every year in between?
    15. Global production breakup of global stroke revascularization  device market, by suppliers and their OEM relationship

     

     

    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix

     

     

     

     

     

     

     

    0
      0
      Your Cart
      Your cart is emptyReturn to Shop